top
Please input keywords
Order
*Country
한국
미국
일본
중국
영국
호주
프랑스
독일
이탈리아
싱가포르
인도
러시아
캐나다
스위스
기타 국가
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-hPD-L1 low B16-F10
Common name
B-hPD-L1 low B16-F10 Catalog number     310890
Aliases B7-H, B7H1, PDCD1L1, PDCD1LG1 Disease  Melanoma
Organism
Mouse
Strain  C57BL/6
Tissue types Skin Tissue  Skin

Description 


The mouse Pdl1 gene was replaced by human PD-L1 coding sequence in B-hPD-L1 low B16-F10 cells. Human PD-L1 is expressed on the surface of B-hPD-L1 low B16-F10 cells.


Application


B-hPD-L1 low B16-F10 cells have the capability to establish tumors in vivo and can be used for efficacy studies.


Targeting strategy


The exogenous promoter and human PD-L1 coding sequence was inserted to replace part of murine exon 3. The insertion disrupts the endogenous murine Pdl1 gene, resulting in a non-functional transcript.


Protein expression analysis 


from clipboard


PD-L1 expression analysis in B-hPD-L1 low B16-F10 cells by flow cytometry. Single cell suspensions from wild-type B16-F10, B-hPD-L1 B16-F10 and B-hPD-L1 low B16-F10 cultures were stained with species-specific anti-PD-L1 antibody. Mouse PD-L1 was detectable in wild-type B16-F10 cells. Human PD-L1 was detectable in B-hPD-L1 low B16-F10 cells, and human PD-L1 was expressed highly on the surface of B-hPD-L1 B16-F10 cells. The 2-G02 clone of B-hPD-L1 low B16-F10 cells was used for in vivo experiments.


Tumor growth curve & Body weight changes


from clipboard


Subcutaneous homograft tumor growth of B-hPD-L1 low B16-F10 cells. Wild-type B16-F10, B-hPD-L1 B16-F10 and B-hPD-L1 low B16-F10 cells (2x105) were subcutaneously implanted into C57BL/6 mice (female, 7-8-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hPD-L1 low B16-F10 cells were able to establish tumors in vivo and can be used for efficacy studies.

Protein expression analysis of tumor cells

from clipboard

B-hPD-L1 low B16-F10 and B-hPD-L1 B16-F10 cells were subcutaneously transplanted into C57BL/6 mice (n=5). At the end of the experiment, tumor cells were harvested and assessed for human PD-L1 expression by flow cytometry. As shown, human PD-L1 was expressed on the surface of B-hPD-L1 low B16-F10 tumor cells, and it was expressed highly on the surface of B-hPD-L1 B16-F10 tumor cells. Therefore, B-hPD-L1 low B16-F10 cells can be used for in vivo efficacy studies of novel PD-L1 therapeutics.
FMO Control: tumor cells only stained anti-hPD-L1 antibody.